U.S. President Donald Trump's decision to put a halt to U.S. foreign aid sparked intense and swift panic last month, but a partial U-turn has done little to calm nerves, fueling a debate about the viability of the global aid system.
Hours after his inauguration on Jan. 20, Trump ordered a 90-day pause in foreign aid, including the supply of drugs for HIV treatment under the President's Emergency Plan for AIDS Relief (PEPFAR), the world's leading HIV initiative.
As charities and development agencies reeled at the speed and scale of the policy change, people like Harrison Ibeh, a 32-year-old gay Nigerian who is HIV positive, wondered how they would cope without life-saving antiretroviral (ARV) therapies.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.